Search research articles
Contact Us
Filters
Showing results (181-190 of 213) with videos related to
Page
of 22
Sort By:
American Journal of Hematology
|
May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease
Alex George, Bogdan Dinu, Norma Estrada, et al.
Journal of Pediatric Psychology
|
July 3, 2025
Mood and sleep in young adults with type 1 diabetes
Samantha A Carreon, Marissa N Baudino, Charles G Minard, et al.
Brain Connectivity
|
August 8, 2017
Correlating Resting-State Functional Magnetic Resonance Imaging Connectivity by Independent Component Analysis-Based Epileptogenic Zones with Intracranial Electroencephalogram Localized Seizure Onset Zones and Surgical Outcomes in Prospective Pediatric Intractable Epilepsy Study
Varina L Boerwinkle, Deepankar Mohanty, Stephen T Foldes, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2017
Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events
Courtenay R Bruce, Charles G Minard, L A Wilhelms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer
|
July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors
Sarah B Whittle, Valeria Smith, Allison Silverstein, et al.
Pediatric Blood & Cancer
|
May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
Contemporary Clinical Trials
|
October 12, 2024
DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care
Samantha A Carreon, Charles G Minard, Sarah K Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial
Adam L Green, Charles G Minard, Xiaowei Liu, et al.
Contemporary Clinical Trials
|
June 7, 2025
Corrigendum to "DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care" [Contemporary Clinical Trials Volume 147, December 2024, 107713]
Samantha A Carreon, Charles G Minard, Sarah K Lyons, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 213) with videos related to
Sort By:
Page
of 22
American Journal of Hematology
|
May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease
Alex George, Bogdan Dinu, Norma Estrada, et al.
Journal of Pediatric Psychology
|
July 3, 2025
Mood and sleep in young adults with type 1 diabetes
Samantha A Carreon, Marissa N Baudino, Charles G Minard, et al.
Brain Connectivity
|
August 8, 2017
Correlating Resting-State Functional Magnetic Resonance Imaging Connectivity by Independent Component Analysis-Based Epileptogenic Zones with Intracranial Electroencephalogram Localized Seizure Onset Zones and Surgical Outcomes in Prospective Pediatric Intractable Epilepsy Study
Varina L Boerwinkle, Deepankar Mohanty, Stephen T Foldes, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2017
Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events
Courtenay R Bruce, Charles G Minard, L A Wilhelms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Pediatric Blood & Cancer
|
July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors
Sarah B Whittle, Valeria Smith, Allison Silverstein, et al.
Pediatric Blood & Cancer
|
May 3, 2018
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
Eric S Schafer, Rachel E Rau, Stacey Berg, et al.
Contemporary Clinical Trials
|
October 12, 2024
DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care
Samantha A Carreon, Charles G Minard, Sarah K Lyons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2025
Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial
Adam L Green, Charles G Minard, Xiaowei Liu, et al.
Contemporary Clinical Trials
|
June 7, 2025
Corrigendum to "DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care" [Contemporary Clinical Trials Volume 147, December 2024, 107713]
Samantha A Carreon, Charles G Minard, Sarah K Lyons, et al.
Page
of 22